Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00598819 · ClinicalTrials.gov registry record · Phase 1

A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers

A Phase 1 study, sponsored by University of California, Irvine.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target

NCT00598819 is a Phase 1 study that has completed, run by University of California, Irvine. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00598819, a Phase 1 study, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a new cerebral oxygen monitoring device is effective and comparatively similar to the current approved devices.

Interventions

  • DEVICE CDI 1000 COM

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2007-10
Est. Completion 2009-05
Phase Phase 1

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT00598819

The ClinicalTrials.gov registry entry for NCT00598819 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CDI 1000 COM is the first listed.

NCT00598819 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00598819 about?

NCT00598819 is a clinical study titled "A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers". The purpose of this study is to determine whether a new cerebral oxygen monitoring device is effective and comparatively similar to the current approved devices.

What is the current status of trial NCT00598819?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2007-10. Estimated completion is 2009-05.

What interventions are being tested in trial NCT00598819?

The interventions under investigation include: CDI 1000 COM (DEVICE).

Who is sponsoring clinical trial NCT00598819?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.